RBM4 and non-small cell lung carcinoma: To explore the clinical relevance of the AURKA-RBM4 aberrant splicing axis, we collected 8 pairs of non-small cell lung cancer (NSCLC) specimens and adjacent normal tissues to measure the protein levels of AURKA and RBM4 two splicing isoforms.